A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Actym Therapeutics, Inc.
Pfizer
MacroGenics
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Anza Therapeutics, Inc.